Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
TOKYO, November 22, 2022 – FUJIFILM Corporation (President and
CEO, Representative Director: Teiichi Goto) today announced a $188
million investment to establish a cell culture media manufacturing
facility in Research Triangle Park (RTP), North Carolina, USA. The new
site will be operated by FUJIFILM Irvine Scientific, Inc., a subsidiary
of FUJIFILM Corporation, and a world leader in the development and
manufacture of advanced cell culture solutions for life science
research, bioproduction, cell therapy manufacturing, and medical
applications. The new facility is planned to ensure that FUJIFILM Irvine
Scientific can meet increasing market demands for high quality cell
culture media solutions.
More info >> |